Although MASP has been characterised as a tumour suppressor, its overexpression is suggested to play a key role in tumour progression as well as enhanced aggressiveness for various cancers such as breast, gastric and pancreatic [101,102]. This evidence concerns the gene MASP1 and neoplasm.